1. Home
  2. ERIC vs TEVA Comparison

ERIC vs TEVA Comparison

Compare ERIC & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ericsson

ERIC

Ericsson

N/A

Current Price

$12.64

Market Cap

44.9B

Sector

Technology

ML Signal

N/A

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

N/A

Current Price

$34.46

Market Cap

39.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERIC
TEVA
Founded
1876
1901
Country
Sweden
Israel
Employees
88826
32842
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9B
39.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ERIC
TEVA
Price
$12.64
$34.46
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$11.00
$38.63
AVG Volume (30 Days)
9.8M
4.7M
Earning Date
04-17-2026
04-29-2026
Dividend Yield
1.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.83
$2.97
P/E Ratio
$12.13
$28.19
Revenue Growth
N/A
N/A
52 Week Low
$7.16
$14.99
52 Week High
$13.77
$37.35

Technical Indicators

Market Signals
Indicator
ERIC
TEVA
Relative Strength Index (RSI) 49.54 51.83
Support Level $9.37 $33.61
Resistance Level N/A $35.37
Average True Range (ATR) 0.33 0.88
MACD -0.09 -0.17
Stochastic Oscillator 12.70 63.34

Price Performance

Historical Comparison
ERIC
TEVA

About ERIC Ericsson

Ericsson is a networking equipment and software provider, primarily selling mobile networking equipment and services to wireless service providers. Ericsson operates in three segments: networks, cloud software and services, and enterprise. While large wireless carriers are its largest customers, Ericsson has expanded its offerings for large enterprises. These products and services include private 5G networking, contact centers as a service, and application performance interfaces. Ericsson aims to combine its 5G network expertise with cloud-native, as-a-service platforms offering a more comprehensive hardware and software package. Ericsson also monetizes its research and development investments by licensing patents to handset manufacturers.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: